{"product_id":"histologic-basis-of-ocular-disease-in-animals-isbn-9781118388778","title":"Histologic Basis of Ocular Disease in Animals","description":"\u003cp\u003e\u003ci\u003eHistologic Basis of Ocular Disease in Animals\u003c\/i\u003e is a comprehensive reference covering pathology of the eye in a spectrum of animal species, including domestic animals, fish, birds, and laboratory animals.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eOffers a comprehensive resource on diseases and conditions of the eye and orbit in a wide range of species\u003c\/li\u003e \u003cli\u003eCovers domestic animals, fish, birds, and laboratory animals\u003c\/li\u003e \u003cli\u003ePresents more than 1200 high-quality images carefully selected to illustrate the ocular conditions covered\u003c\/li\u003e \u003cli\u003eEmphasizes unique pathological responses where necessary\u003c\/li\u003e \u003c\/ul\u003eHistologic Basis of Ocular Disease in Animals ist ein umfassendes Referenzwerk zur Pathologie der Augen bei einer ganzen Reihe von Tierarten, u. a. Haustiere, Fische, Vögel und Laborversuchstiere.\u003cbr\u003e - Umfassendes Nachschlagewerk zu Erkrankungen und Störungen von Auge und Augenhöhle bei einer Vielzahl von Tierarten.\u003cbr\u003e - Deckt auch Haustiere, Fische, Vögel und Laborversuchstiere ab.\u003cbr\u003e - Enthält mehr als 1200 hochwertige Bilder, die sorgfältig ausgesucht wurden, um die vorgestellten Augenerkrankungen darzustellen.\u003cbr\u003e - Legt den Schwerpunkt auf einzigartige pathologische Reaktion, wenn erforderlich.\u003cbr\u003e \u003cp\u003eForeword xiii\u003c\/p\u003e \u003cp\u003eAcknowledgements xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Fixation and processing of ocular tissues 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFixatives 1\u003c\/p\u003e \u003cp\u003eFixation and sectioning artifacts 2\u003c\/p\u003e \u003cp\u003eFixation techniques 3\u003c\/p\u003e \u003cp\u003eTrimming the fixed globe 5\u003c\/p\u003e \u003cp\u003eElectron microscopy 13\u003c\/p\u003e \u003cp\u003eReferences 14\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 General pathology of the eye 15\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAdaptations characterized by changes in cell size, number, or appearance 15\u003c\/p\u003e \u003cp\u003eNeoplasia 19\u003c\/p\u003e \u003cp\u003eNomenclature 23\u003c\/p\u003e \u003cp\u003eDistinguishing benign from malignant 25\u003c\/p\u003e \u003cp\u003ePrognostication 27\u003c\/p\u003e \u003cp\u003eUnsuccessful adaptation: cellular degeneration, necrosis, and apoptosis 27\u003c\/p\u003e \u003cp\u003eCalcification, pigmentation, and cystic change 30\u003c\/p\u003e \u003cp\u003eOcular inflammation 32\u003c\/p\u003e \u003cp\u003eOcular manifestations of acute inflammation 34\u003c\/p\u003e \u003cp\u003eChronic inflammation 39\u003c\/p\u003e \u003cp\u003eOcular manifestations of chronic inflammation 39\u003c\/p\u003e \u003cp\u003eImmune privilege 41\u003c\/p\u003e \u003cp\u003eLymphocytic–plasmacytic endophthalmitis 42\u003c\/p\u003e \u003cp\u003eThe sequelae of intraocular inflammation and other injuries 43\u003c\/p\u003e \u003cp\u003eLimited regenerative ability 43\u003c\/p\u003e \u003cp\u003eSusceptibility to scarring 43\u003c\/p\u003e \u003cp\u003eFurther reading 46\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Congenital anomalies 49\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 49\u003c\/p\u003e \u003cp\u003eDefective organogenesis 50\u003c\/p\u003e \u003cp\u003eDefective early organogenesis 50\u003c\/p\u003e \u003cp\u003eAnophthalmos and cystic globe 53\u003c\/p\u003e \u003cp\u003eAnophthalmos and microphthalmos 54\u003c\/p\u003e \u003cp\u003eCyclopia and synophthalmos 56\u003c\/p\u003e \u003cp\u003eCongenital anomalies of lens 56\u003c\/p\u003e \u003cp\u003eCongenital retinal nonattachment 63\u003c\/p\u003e \u003cp\u003eAniridia – iridal hypoplasia or aplasia 63\u003c\/p\u003e \u003cp\u003eColoboma 63\u003c\/p\u003e \u003cp\u003eDefective later organogenesis 64\u003c\/p\u003e \u003cp\u003eNeurectodermal defects 64\u003c\/p\u003e \u003cp\u003eMultifocal retinopathies 71\u003c\/p\u003e \u003cp\u003eMultiple ocular anomalies (MOA) in Rocky Mountain horses 71\u003c\/p\u003e \u003cp\u003eAnomalies of surface ectodermal origin that develop during later organogenesis 73\u003c\/p\u003e \u003cp\u003eCongenital adnexal cysts 73\u003c\/p\u003e \u003cp\u003eDermoids 73\u003c\/p\u003e \u003cp\u003eDefects of neural crest migration and mesenchymal differentiation that develop in later organogenesis 73\u003c\/p\u003e \u003cp\u003eCongenital corneal disease 73\u003c\/p\u003e \u003cp\u003eCongenital disorders of neurocrest and mesenchymal tissues that manifest in the uvea during later organogenesis 74\u003c\/p\u003e \u003cp\u003ePersistent pupillary membranes (PPMs) 74\u003c\/p\u003e \u003cp\u003eCongenital glaucoma 75\u003c\/p\u003e \u003cp\u003eUveal hypoplasia 78\u003c\/p\u003e \u003cp\u003eCollie eye anomaly (CEA) and related defects 78\u003c\/p\u003e \u003cp\u003ePersistence of embryonic vasculature 81\u003c\/p\u003e \u003cp\u003eReferences 83\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Histopathology of ocular trauma 89\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePerforating and penetrating wounds of the globe and ocular tissues 89\u003c\/p\u003e \u003cp\u003ePerforating wounds of the globe 89\u003c\/p\u003e \u003cp\u003eTraumatic intraocular hemorrhage 89\u003c\/p\u003e \u003cp\u003eExpulsive subchoroidal hemorrhage 90\u003c\/p\u003e \u003cp\u003eSequelae of intraocular hemorrhage 90\u003c\/p\u003e \u003cp\u003ePosttraumatic inflammation 95\u003c\/p\u003e \u003cp\u003ePhacoclastic endophthalmitis and traumatic cataract 95\u003c\/p\u003e \u003cp\u003eInfectious endophthalmitis 95\u003c\/p\u003e \u003cp\u003eTrauma to individual ocular tissues 95\u003c\/p\u003e \u003cp\u003eOrbit and optic nerve 95\u003c\/p\u003e \u003cp\u003eCornea\/sclera 95\u003c\/p\u003e \u003cp\u003eUvea 100\u003c\/p\u003e \u003cp\u003eLens 101\u003c\/p\u003e \u003cp\u003eVitreous and retina 101\u003c\/p\u003e \u003cp\u003eGlobe as a whole 101\u003c\/p\u003e \u003cp\u003eReaction to foreign materials 101\u003c\/p\u003e \u003cp\u003eComplications of ocular surgery 102\u003c\/p\u003e \u003cp\u003eChemical and thermal burns 102\u003c\/p\u003e \u003cp\u003eEffects of radiant energy 103\u003c\/p\u003e \u003cp\u003eReferences 103\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Diseases of the eyelid, conjunctiva, lacrimal, and nasolacrimal systems 105\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEyelids 105\u003c\/p\u003e \u003cp\u003eStructural disorders 105\u003c\/p\u003e \u003cp\u003eDermoids 105\u003c\/p\u003e \u003cp\u003eHamartomas 105\u003c\/p\u003e \u003cp\u003eSubconjunctival fat prolapse 105\u003c\/p\u003e \u003cp\u003eEntropion, ectropion, and medial canthal pocket syndrome 105\u003c\/p\u003e \u003cp\u003eDistichiasis, districhiasis, and ectopic cilia 106\u003c\/p\u003e \u003cp\u003eInflammatory disease 108\u003c\/p\u003e \u003cp\u003ePyogranulomatous (granulomatous) blepharitis 108\u003c\/p\u003e \u003cp\u003eJuvenile sterile granulomatous dermatitis and lymphadenitis (juvenile cellulitis) 110\u003c\/p\u003e \u003cp\u003eChalazion 110\u003c\/p\u003e \u003cp\u003eMedial canthal erosion syndrome 111\u003c\/p\u003e \u003cp\u003eProliferative pox virus blepharitis in birds 111\u003c\/p\u003e \u003cp\u003eParasitic eyelid disorders 111\u003c\/p\u003e \u003cp\u003eDemodicosis 111\u003c\/p\u003e \u003cp\u003eCnemidocoptes pilae (scaly beak) infestation of avian species 113\u003c\/p\u003e \u003cp\u003eEyelid tumors and neoplasms 113\u003c\/p\u003e \u003cp\u003eCystic apocrine hyperplasia (hidrocystomas, sudoriferous cysts, and apocrine cysts) 113\u003c\/p\u003e \u003cp\u003eGranular cell tumor 113\u003c\/p\u003e \u003cp\u003eMeibomian (tarsal gland) adenoma 115\u003c\/p\u003e \u003cp\u003eMelanocytoma and melanoma 115\u003c\/p\u003e \u003cp\u003eHistiocytoma 118\u003c\/p\u003e \u003cp\u003eMast cell tumor 118\u003c\/p\u003e \u003cp\u003ePeripheral nerve sheath tumors 118\u003c\/p\u003e \u003cp\u003eEquine sarcoid 121\u003c\/p\u003e \u003cp\u003eSquamous cell carcinoma 122\u003c\/p\u003e \u003cp\u003eDiseases of the conjunctiva 123\u003c\/p\u003e \u003cp\u003eGeneral pathology of the conjunctiva 124\u003c\/p\u003e \u003cp\u003eCongenital conjunctival abnormalities 124\u003c\/p\u003e \u003cp\u003eInfectious conjunctivitis 126\u003c\/p\u003e \u003cp\u003eHerpesvirus 126\u003c\/p\u003e \u003cp\u003eChlamydophila (chlamydia) 126\u003c\/p\u003e \u003cp\u003eRickettsia rickettsi 126\u003c\/p\u003e \u003cp\u003eMoraxella bovis 126\u003c\/p\u003e \u003cp\u003eParasitic conjunctivitis 126\u003c\/p\u003e \u003cp\u003eNoninfectious inflammatory disease 127\u003c\/p\u003e \u003cp\u003eEpisclerokerataconjunctivitis 127\u003c\/p\u003e \u003cp\u003eLipogranulomatous conjunctivitis of cats 127\u003c\/p\u003e \u003cp\u003eEosinophilic conjunctivitis 128\u003c\/p\u003e \u003cp\u003eMiscellaneous conjunctival disorders 128\u003c\/p\u003e \u003cp\u003eConjunctival overgrowth in rabbits (pseudopterygium) 128\u003c\/p\u003e \u003cp\u003eMembranous (ligneous) conjunctivitis 129\u003c\/p\u003e \u003cp\u003eConjunctival neoplasms 129\u003c\/p\u003e \u003cp\u003eConjunctival lymphoma 129\u003c\/p\u003e \u003cp\u003eConjunctival mast cell tumors 130\u003c\/p\u003e \u003cp\u003eConjunctival melanoma and melanocytoma 130\u003c\/p\u003e \u003cp\u003eViral papillomas 133\u003c\/p\u003e \u003cp\u003eConjunctiva squamous papilloma 133\u003c\/p\u003e \u003cp\u003eConjunctival squamous cell carcinoma 133\u003c\/p\u003e \u003cp\u003eConjunctival vascular neoplasia 133\u003c\/p\u003e \u003cp\u003eMiscellaneous neoplasms of the third eyelid 133\u003c\/p\u003e \u003cp\u003eLacrimal and nasolacrimal disorders 136\u003c\/p\u003e \u003cp\u003eNeoplasms of the gland of the third eyelid 136\u003c\/p\u003e \u003cp\u003eProlapsed gland of the third eyelid 138\u003c\/p\u003e \u003cp\u003eKeratoconjunctivitis sicca (KCS) 138\u003c\/p\u003e \u003cp\u003eDacryops and canaliculops 138\u003c\/p\u003e \u003cp\u003eReferences 138\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Diseases of the cornea 143\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCorneal wound healing 143\u003c\/p\u003e \u003cp\u003eEpithelial wound healing 143\u003c\/p\u003e \u003cp\u003eStromal wound healing 147\u003c\/p\u003e \u003cp\u003eEndothelial wound healing 149\u003c\/p\u003e \u003cp\u003eEpithelial and fibrous ingrowth 151\u003c\/p\u003e \u003cp\u003eHealing of corneal grafts 152\u003c\/p\u003e \u003cp\u003eNonspecific corneal responses to insult 152\u003c\/p\u003e \u003cp\u003eCorneal vascularization 152\u003c\/p\u003e \u003cp\u003eCorneal pigmentation 154\u003c\/p\u003e \u003cp\u003eCorneal edema 154\u003c\/p\u003e \u003cp\u003eKeratitis 154\u003c\/p\u003e \u003cp\u003eEpithelial alterations of keratitis 154\u003c\/p\u003e \u003cp\u003eStromal alterations of keratitis 156\u003c\/p\u003e \u003cp\u003eEndothelialitis 158\u003c\/p\u003e \u003cp\u003eSpecific inflammatory corneal disease 159\u003c\/p\u003e \u003cp\u003eImmune‐mediated nonulcerative keratitis 159\u003c\/p\u003e \u003cp\u003eImmune‐mediated ulcerative keratitis 159\u003c\/p\u003e \u003cp\u003eSuperficial punctate keratitis (punctate erosive corneal dystrophy) 159\u003c\/p\u003e \u003cp\u003eChronic superficial keratitis (pannus) 159\u003c\/p\u003e \u003cp\u003eEosinophilic keratitis 161\u003c\/p\u003e \u003cp\u003eMiscellaneous corneal disorders: corneal sequestrum, indolent corneal ulceration, corneal dystrophy, corneal lipid infiltrates, and corneal degeneration 161\u003c\/p\u003e \u003cp\u003eCorneal sequestrum 161\u003c\/p\u003e \u003cp\u003eIndolent ulceration (boxer ulcer, spontaneous corneal epithelial defects) 164\u003c\/p\u003e \u003cp\u003eCorneal dystrophies, corneal lipid infiltrates, and corneal calcific\/lipid degeneration 165\u003c\/p\u003e \u003cp\u003eMiscellaneous corneal disease 167\u003c\/p\u003e \u003cp\u003eCorneal neoplasia 172\u003c\/p\u003e \u003cp\u003eReferences 177\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Diseases of the episclera and sclera 181\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePrimary episcleral and scleral inflammatory disorders: a brief introduction 181\u003c\/p\u003e \u003cp\u003eSecondary scleritis 181\u003c\/p\u003e \u003cp\u003eScleral neoplasia 182\u003c\/p\u003e \u003cp\u003eLimbal melanocytoma 184\u003c\/p\u003e \u003cp\u003eEpiscleritis (episclerokeratitis, episclerokeratoconjunctivitis) 185\u003c\/p\u003e \u003cp\u003eScleritis and necrotizing scleritis a continuum or separate conditions? 189\u003c\/p\u003e \u003cp\u003eNon‐necrotizing scleritis 193\u003c\/p\u003e \u003cp\u003eNecrotizing scleritis 195\u003c\/p\u003e \u003cp\u003eParasitic episcleral disease (onchocerca vulpis\/lienalis) 195\u003c\/p\u003e \u003cp\u003eReferences 196\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Histologic manifestations of disorders of the uvea 197\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNormal aging changes 203\u003c\/p\u003e \u003cp\u003eDegenerative diseases of the uvea 205\u003c\/p\u003e \u003cp\u003eUveal atrophy 205\u003c\/p\u003e \u003cp\u003eUveal cysts 205\u003c\/p\u003e \u003cp\u003eCystoid degeneration of the pars plana ciliary epithelium 205\u003c\/p\u003e \u003cp\u003ePre‐iridal fibrovascular membranes (PIFMs) 208\u003c\/p\u003e \u003cp\u003eHeterotopic bony metaplasia of the ciliary body in guinea pigs 208\u003c\/p\u003e \u003cp\u003eUveitis 210\u003c\/p\u003e \u003cp\u003eThe nomenclature of uveitis 210\u003c\/p\u003e \u003cp\u003eThe intraocular events of uveitis 210\u003c\/p\u003e \u003cp\u003eThe etiologic implications of inflammatory exudates 216\u003c\/p\u003e \u003cp\u003eImmune privilege 218\u003c\/p\u003e \u003cp\u003eConsequences of uveitis 218\u003c\/p\u003e \u003cp\u003eHistologic basis of the common infectious, idiopathic, and immune‐mediated uveitis syndromes in domestic animals 221\u003c\/p\u003e \u003cp\u003eLens‐induced uveitis 221\u003c\/p\u003e \u003cp\u003ePhacolytic uveitis 223\u003c\/p\u003e \u003cp\u003ePhacoclastic uveitis 224\u003c\/p\u003e \u003cp\u003eEquine recurrent uveitis 227\u003c\/p\u003e \u003cp\u003eFeline lymphocytic–plasmacytic uveitis 231\u003c\/p\u003e \u003cp\u003ePigmentary uveitis\/pigmentary glaucoma of dogs 231\u003c\/p\u003e \u003cp\u003eEquine heterochromic iridocyclitis with secondary keratitis 233\u003c\/p\u003e \u003cp\u003eVogt–Koyanagi–Harada‐like or uveodermatologic syndrome in dogs 233\u003c\/p\u003e \u003cp\u003eUveal xanthogranuloma in miniature schnauzers 235\u003c\/p\u003e \u003cp\u003eUveitis associated with specific infectious agents 235\u003c\/p\u003e \u003cp\u003eViruses 235\u003c\/p\u003e \u003cp\u003eFeline infectious peritonitis 235\u003c\/p\u003e \u003cp\u003eCanine adenovirus‐associated uveitis 238\u003c\/p\u003e \u003cp\u003eCanine distemper virus‐associated uveitis 239\u003c\/p\u003e \u003cp\u003eBovine malignant catarrhal fever (MCF)‐associated uveitis 239\u003c\/p\u003e \u003cp\u003eBovine viral diarrhea mucosal disease‐associated uveitis 239\u003c\/p\u003e \u003cp\u003eOvine bluetongue 239\u003c\/p\u003e \u003cp\u003eEquine viral arteritis (EVA)‐associated uveitis 239\u003c\/p\u003e \u003cp\u003eWest Nile‐associated avian uveitis 239\u003c\/p\u003e \u003cp\u003eHog cholera 239\u003c\/p\u003e \u003cp\u003eBacteria 240\u003c\/p\u003e \u003cp\u003eFungi 241\u003c\/p\u003e \u003cp\u003eOther infectious causes for endophthalmitis 245\u003c\/p\u003e \u003cp\u003eAlgal endophthalmitis 246\u003c\/p\u003e \u003cp\u003eProtozoan endophthalmitis 246\u003c\/p\u003e \u003cp\u003eMetazoan parasitic uveitis 246\u003c\/p\u003e \u003cp\u003eReferences 250\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Histologic basis of glaucoma 255\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 255\u003c\/p\u003e \u003cp\u003eThe gross, subgross, and histologic lesions of elevated IOP 255\u003c\/p\u003e \u003cp\u003eRetinal changes 257\u003c\/p\u003e \u003cp\u003eOptic nerve changes 262\u003c\/p\u003e \u003cp\u003eClassification of canine glaucoma and introduction to open and closed angles 266\u003c\/p\u003e \u003cp\u003eCongenital glaucoma 267\u003c\/p\u003e \u003cp\u003ePrimary glaucoma 270\u003c\/p\u003e \u003cp\u003eOpen angle glaucoma of beagle dogs 274\u003c\/p\u003e \u003cp\u003ePrimary (congenital) glaucoma in New Zealand white rabbit 274\u003c\/p\u003e \u003cp\u003eSecondary glaucoma 274\u003c\/p\u003e \u003cp\u003ePre‐iridal Fibrovascular Membrane 274\u003c\/p\u003e \u003cp\u003ePosterior Synechia with Pupillary Block 275\u003c\/p\u003e \u003cp\u003eVitreous degeneration, syneresis, and anterior chamber prolapse 275\u003c\/p\u003e \u003cp\u003eTrabecular obstruction by tumor 278\u003c\/p\u003e \u003cp\u003eOther causes of secondary glaucoma in dogs 278\u003c\/p\u003e \u003cp\u003eGlaucoma in cats 283\u003c\/p\u003e \u003cp\u003eGlaucoma in horses 284\u003c\/p\u003e \u003cp\u003eReferences 286\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Histologic manifestations of acquired and inherited diseases of the lens 289\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEmbryology and anatomy of the lens 289\u003c\/p\u003e \u003cp\u003ePhysiology of the lens 292\u003c\/p\u003e \u003cp\u003ePathology of the lens 292\u003c\/p\u003e \u003cp\u003eAging changes 294\u003c\/p\u003e \u003cp\u003eCataract 294\u003c\/p\u003e \u003cp\u003eThe classification of cataracts 294\u003c\/p\u003e \u003cp\u003eThe histopathology of cataract 294\u003c\/p\u003e \u003cp\u003eThe pathogenesis of cataracts 299\u003c\/p\u003e \u003cp\u003eEtiologies of cataract 299\u003c\/p\u003e \u003cp\u003eLens luxation 302\u003c\/p\u003e \u003cp\u003eInherited lens zonular dysplasia 303\u003c\/p\u003e \u003cp\u003eReferences 305\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Acquired diseases of the vitreous 307\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePrimary disorders of the vitreous 310\u003c\/p\u003e \u003cp\u003eVitreous degeneration 310\u003c\/p\u003e \u003cp\u003eAsteroid hyalosis 315\u003c\/p\u003e \u003cp\u003ePosterior vitreous detachment 315\u003c\/p\u003e \u003cp\u003eSynchisis scintillans 315\u003c\/p\u003e \u003cp\u003eUveal and neuroectodermal pigment and cysts within the vitreous and incidental parasitic encounters 317\u003c\/p\u003e \u003cp\u003eNeovascularization 317\u003c\/p\u003e \u003cp\u003eConditions with secondary vitreous involvement 317\u003c\/p\u003e \u003cp\u003eVitritis 317\u003c\/p\u003e \u003cp\u003eVitreous hemorrhage 319\u003c\/p\u003e \u003cp\u003eReferences 322\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Histologic manifestations of retinal disease 325\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 325\u003c\/p\u003e \u003cp\u003eRetinal diseases by histologic pattern 328\u003c\/p\u003e \u003cp\u003eRetinal atrophy 329\u003c\/p\u003e \u003cp\u003eInner retinal atrophies 329\u003c\/p\u003e \u003cp\u003eThe pathogenesis of retinal degeneration secondary to glaucoma 329\u003c\/p\u003e \u003cp\u003eRetinal atrophy secondary to non‐glaucomatous optic nerve injury and vascular disease 335\u003c\/p\u003e \u003cp\u003eOptic nerve hypoplasia\/aplasia 336\u003c\/p\u003e \u003cp\u003eOuter retinal (photoreceptor) atrophies 336\u003c\/p\u003e \u003cp\u003eInherited photoreceptor dysplasias and degenerations 336\u003c\/p\u003e \u003cp\u003eRetinal detachment 340\u003c\/p\u003e \u003cp\u003eToxic and nutritional retinopathies 346\u003c\/p\u003e \u003cp\u003eFluoroquinolone‐induced retinal degeneration 346\u003c\/p\u003e \u003cp\u003eVitamin A deficiency 347\u003c\/p\u003e \u003cp\u003eVitamin E deficiency 347\u003c\/p\u003e \u003cp\u003eTaurine deficiency 347\u003c\/p\u003e \u003cp\u003eLight‐induced retinal degeneration 347\u003c\/p\u003e \u003cp\u003eSudden acquired retinal degeneration (SARD) and immune mediated retinopathy (IMR) of dogs 352\u003c\/p\u003e \u003cp\u003eDiseases targeting the retinal pigment epithelium 352\u003c\/p\u003e \u003cp\u003eRetinal pigment epithelial dystrophy (central progressive retinal atrophy) 352\u003c\/p\u003e \u003cp\u003eHereditary retinal pigment epithelial disorders (congenital stationary night blindness of briard dogs, multifocal retinopathies) 352\u003c\/p\u003e \u003cp\u003eCanine multifocal retinopathy 354\u003c\/p\u003e \u003cp\u003eRetinal pigment epithelial dysplasia in the royal college of surgeons rat 354\u003c\/p\u003e \u003cp\u003eLocalized chorioretinal atrophy in rats 354\u003c\/p\u003e \u003cp\u003eRetinitis 354\u003c\/p\u003e \u003cp\u003eBystander retinitis 356\u003c\/p\u003e \u003cp\u003eRetinitis as a manifestation of neurologic disease 356\u003c\/p\u003e \u003cp\u003eHistophilus somni (formerly Hemophilus somnus) infection in cattle 356\u003c\/p\u003e \u003cp\u003eCanine distemper 356\u003c\/p\u003e \u003cp\u003eRetinal lesions reflecting noninfectious systemic disease 357\u003c\/p\u003e \u003cp\u003eRetinal lesions of systemic hypertension 357\u003c\/p\u003e \u003cp\u003eRetinal lesions resulting from inborn errors in the intermediary metabolism (lysosomal storage diseases and others) 357\u003c\/p\u003e \u003cp\u003eRetinal injury from thermal energy 358\u003c\/p\u003e \u003cp\u003eRetinal neoplasms 358\u003c\/p\u003e \u003cp\u003eMedullopitheliomas 360\u003c\/p\u003e \u003cp\u003eRetinoblastoma 360\u003c\/p\u003e \u003cp\u003eReferences 360\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Acquired diseases of the optic nerve 367\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntraocular disorders with associated optic neuropathy 367\u003c\/p\u003e \u003cp\u003eGlaucomatous optic neuropathy 367\u003c\/p\u003e \u003cp\u003eEndophthalmitis and ascending optic neuritis 372\u003c\/p\u003e \u003cp\u003eCanine distemper optic neuritis 372\u003c\/p\u003e \u003cp\u003eOrbital disorders that affect the optic nerve 372\u003c\/p\u003e \u003cp\u003eProptotic optic neuropathy 372\u003c\/p\u003e \u003cp\u003eOrbital cellulitis\/abscess with optic nerve sepsis 372\u003c\/p\u003e \u003cp\u003eCNS conditions that affect the optic nerve 372\u003c\/p\u003e \u003cp\u003eOptic nerve disorders 376\u003c\/p\u003e \u003cp\u003eGranulomatous meningoencephalitis 376\u003c\/p\u003e \u003cp\u003eUnilateral granulomatous optic neuritis 376\u003c\/p\u003e \u003cp\u003eOptic neuropathy in horses 376\u003c\/p\u003e \u003cp\u003eFeline optic neuropathies 376\u003c\/p\u003e \u003cp\u003eOther causes of optic neuritis 378\u003c\/p\u003e \u003cp\u003eToxic optic neuropathy 378\u003c\/p\u003e \u003cp\u003eVitamin A deficiency 379\u003c\/p\u003e \u003cp\u003ePrimary optic nerve neoplasms 381\u003c\/p\u003e \u003cp\u003eMeningioma 381\u003c\/p\u003e \u003cp\u003eOptic nerve gliomas 382\u003c\/p\u003e \u003cp\u003ePeripapillary medulloepitheliomas 382\u003c\/p\u003e \u003cp\u003eLymphosarcoma and other metastatic neoplasms 382\u003c\/p\u003e \u003cp\u003eReferences 384\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Acquired diseases of the orbit 387\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 387\u003c\/p\u003e \u003cp\u003eInflammatory disease 387\u003c\/p\u003e \u003cp\u003eExtraocular myositis 388\u003c\/p\u003e \u003cp\u003eLacrimal adenitis 389\u003c\/p\u003e \u003cp\u003eOrbital trauma\/hematoma 390\u003c\/p\u003e \u003cp\u003eZygomatic sialocoele 391\u003c\/p\u003e \u003cp\u003eOrbital cysts and post‐enucleation orbital mucocoeles 393\u003c\/p\u003e \u003cp\u003eParasitic orbital disease 396\u003c\/p\u003e \u003cp\u003eOrbital neoplasia 396\u003c\/p\u003e \u003cp\u003eMultilobular tumor of bone (multilobular osteochondroma) 398\u003c\/p\u003e \u003cp\u003ePrimary orbital osteoma and osteosarcoma 402\u003c\/p\u003e \u003cp\u003eLacrimal adenoma and adenocarcinoma 404\u003c\/p\u003e \u003cp\u003eHarderian gland adenomas and adenocarcinomas 404\u003c\/p\u003e \u003cp\u003eRhabdomyosarcoma 404\u003c\/p\u003e \u003cp\u003eOrbital myofibroblastic sarcoma 404\u003c\/p\u003e \u003cp\u003eVascular anomalies 406\u003c\/p\u003e \u003cp\u003eReferences 406\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Intraocular neoplasia 409\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNon‐neoplastic hyperpigmented lesions 410\u003c\/p\u003e \u003cp\u003eBenign melanocytic neoplasia 410\u003c\/p\u003e \u003cp\u003eUveal melanocytoma 410\u003c\/p\u003e \u003cp\u003eUveal melanocytosis (melanosis) 415\u003c\/p\u003e \u003cp\u003eMalignant uveal melanomas 415\u003c\/p\u003e \u003cp\u003eCanine and feline uveal malignant melanoma 415\u003c\/p\u003e \u003cp\u003eDiffuse iris melanoma of cats 417\u003c\/p\u003e \u003cp\u003eIris and ciliary epithelial neoplasia 422\u003c\/p\u003e \u003cp\u003eMedulloepithelioma and retinoblastoma (primitive neuroectodermal tumors) 426\u003c\/p\u003e \u003cp\u003ePrimary ocular sarcomas of cats and rabbits 428\u003c\/p\u003e \u003cp\u003eSchwannomas of blue eyed dogs 430\u003c\/p\u003e \u003cp\u003eOsteosarcoma and chondrosarcoma 430\u003c\/p\u003e \u003cp\u003eMiscellaneous primary intraocular tumors 432\u003c\/p\u003e \u003cp\u003eMetastatic uveal neoplasia 433\u003c\/p\u003e \u003cp\u003eLymphosarcoma 433\u003c\/p\u003e \u003cp\u003eSecondary intraocular neoplastic extension from primary nasal and orbital and adnexal neoplasms 435\u003c\/p\u003e \u003cp\u003eReferences 436\u003c\/p\u003e \u003cp\u003eIndex 443\u003c\/p\u003e \u003cp\u003e\"Throughout this superbly illustrated textbook, the authors use a combination of histology, gross specimens, and many clinical examples to describe ocular diseases and their underlying pathophysiology...Overall, this book is a valuable and fairly priced resource for veterinary students, veterinarians, and pathologists.\" \u003cb\u003eJAVMA, MAR 15, 2019, VOL 254, NO. 6\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eBruce Grahn, DVM, Diplomate ACVO, ABVP,\u003c\/b\u003e is Professor Emeritus of Veterinary Ophthalmology at the Western College of Veterinary Medicine, Prairie Ocular Pathology Service, University of Saskatchewan in Saskatoon, Saskatchewan, Canada.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eRobert Peiffer, DVM, PhD, Diplomate ACVO,\u003c\/b\u003e is Professor Emeritus of Ophthalmology and Pathology, School of Medicine at the University of North Carolina in Chapel Hill, North Carolina, USA.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eBrian Wilcock, DVM, PhD, Honorary Diplomate ACVO,\u003c\/b\u003e is Professor Emeritus of Pathology, Ontario Veterinary College at the University of Guelph and Owner of Histovet Surgical Pathology in Guelph, Ontario, Canada.\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eHistologic Basis of Ocular Disease in Animals\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003ci\u003eHistologic Basis of Ocular Disease in Animals\u003c\/i\u003e is a comprehensive reference covering pathology of the eye in a spectrum of animal species, including domestic animals, fish, birds, and laboratory animals. With more than 1200 high-quality gross, subgross, and histological images carefully chosen to depict the ocular conditions discussed, the book provides a well-illustrated resource on ocular pathology. Focusing on pathology applicable to the eye in a variety of species, unique pathological responses are highlighted where appropriate. \u003c\/p\u003e\u003cp\u003eThe book presents introductory chapters on handling and processing of ocular tissues and the general pathology of ocular disease. Subsequent chapters highlight the clinical, gross, and histopathologic details of ocular conditions by pathogenesis, tissue, and disease process. The breadth of material is enhanced by pertinent clinical perspectives and extensive references. \u003c\/p\u003e\u003cul\u003e \u003cli\u003e Offers a comprehensive resource on diseases and conditions of the eye and orbit in a wide range of species\u003c\/li\u003e \u003cli\u003e Covers domestic animals, fish, birds, and laboratory animals\u003c\/li\u003e \u003cli\u003e Presents more than 1200 high-quality images carefully selected to illustrate the ocular conditions covered\u003c\/li\u003e \u003cli\u003e Emphasizes unique pathological responses where necessary\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003ci\u003eHistologic Basis of Ocular Disease in Animals\u003c\/i\u003e is an essential reference for veterinary ophthalmologists, veterinary pathologists, and residents in these areas.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989364981989,"sku":"NP9781118388778","price":262.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118388778.jpg?v=1761783828","url":"https:\/\/k12savings.com\/products\/histologic-basis-of-ocular-disease-in-animals-isbn-9781118388778","provider":"K12savings","version":"1.0","type":"link"}